dermatology therapeutics

Verrica Pharmaceuticals Inc (VRCA) Releases Detailed Financial Review of Q1 2024 Performance

Verrica Pharmaceuticals Inc (NASDAQ:VRCA) made waves in the financial world with its impressive first-quarter results for 2024, as reported in…

7 months ago